awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47575272-B9739B2E-AF1E-432E-926D-1103CD4A190F
Q47575272-B9739B2E-AF1E-432E-926D-1103CD4A190F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47575272-B9739B2E-AF1E-432E-926D-1103CD4A190F
Addition of plerixafor to G-CSF is useful to achieve efficient collection even in very poor mobilizers: hope for patients with diminished hematopoietic function.
P2860
Q47575272-B9739B2E-AF1E-432E-926D-1103CD4A190F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47575272-B9739B2E-AF1E-432E-926D-1103CD4A190F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
abe14dca9875bdd2f47b5402ae822b5ae1821d0b
P2860
A nationwide survey of the use of plerixafor in patients with lymphoid malignancies who mobilize poorly demonstrates the predominant use of the "on-demand" scheme of administration at French autologous hematopoietic stem cell transplant programs.